https://doi.org/10.4081/scenario.2011.188
Strategies to reduce the occurrence of ecchymosis in subcutaneous administration of low molecular weight heparin: review of the literature
Submitted: 3 June 2018
Accepted: 3 June 2018
Published: 3 June 2018
Accepted: 3 June 2018
Abstract Views: 1374
PDF (Italiano): 22922
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Introduction:Low molecular weight heparin (LMWH) is used as the therapy of choice for the prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism in both hospital and home settings. One of the most frequent complications of LMWH administration is the appearance of ecchymosis, an event that produces discomfort and concern in the patient. Although LMWH injections are very common, the most effective technique for preventing ecchymosis is not yet clearly documented.
Supporting Agencies
How to Cite
Dante, A., Aidone, E., & Palese, A. (2018). Strategies to reduce the occurrence of ecchymosis in subcutaneous administration of low molecular weight heparin: review of the literature. Scenario® - Il Nursing Nella Sopravvivenza, 28(4), 29–32. https://doi.org/10.4081/scenario.2011.188
Copyright (c) 2018 Scenario
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Aniarti has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.